Presentation is loading. Please wait.

Presentation is loading. Please wait.

U.S. Tissue Engineering Markets Minimizing Costs Key to Market Penetration "At present, tissue repair treatments present a major economic burden to the.

Similar presentations


Presentation on theme: "U.S. Tissue Engineering Markets Minimizing Costs Key to Market Penetration "At present, tissue repair treatments present a major economic burden to the."— Presentation transcript:

1 U.S. Tissue Engineering Markets Minimizing Costs Key to Market Penetration "At present, tissue repair treatments present a major economic burden to the U.S. healthcare structure. The need for cost containment pushes forward the research and development of less costly and more effective third-generation technologies.” Pharmaceuticals Analyst Team Frost & Sullivan

2 Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analytical insights into current topics and emerging applications in the tissue engineering market Market-sizing and competitive analysis Market forecasts and opportunity analyses Quarterly assessments End-user analysis Key Features

3 Coverage: The United States Proven methodology using extensive primary and secondary data as well as research Focused information and strategies that cover business and technology issues Credible data and analyses that highlight industry dynamics Precise strategies to help you create winning business plans What We Offer

4 Current Market Participants Find out where you stand in comparison with the competitors Assess current and future drivers as well as restraints Determine and exploit new market share opportunities New Entrants Analyze the associated challenges Calculate timescales for strategy implementation Position yourself to capitalize on the unmet needs of the market Investment Community Analyze long-term strategies of companies Determine which participants will outperform the competition Assess the attractiveness of investing in the market Who Will Benefit?

5 Advanced Tissue Sciences, Inc. AlloSource American Home Products Corp. Chrysalis BioTechnology, Inc. CO.don Collagenesis, Inc. Cook Biopharma CrossCart, Inc. Cryolife, Inc. Curis, Inc. DePuy/Johnson & Johnson GenSci Regeneration Sciences, Inc. Genzyme BioSurgery/Genzyme Corp. Integra LifeSciences Holdings Corp. Interpore Cross International Johnson & Johnson/Ethicon, Inc. LifeCell Corp. Key Market Participants Medtronic Sofamor Danek The Musculoskeletal Transplant Foundation Novartis AG Organogenesis, Inc. Orquest, Inc. ORTEC International, Inc. OrthoLogic Orthovita, Inc. Osiris Therapeutics, Inc. OsteoBiologics, Inc. Osteotech, Inc. Regeneration Technologies, Inc. Smith & Nephew Sulzer Orthopedics, Inc. Tissue Engineering, Inc. Wright Medical Technology, Inc. Zimmer, Inc.

6 Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information


Download ppt "U.S. Tissue Engineering Markets Minimizing Costs Key to Market Penetration "At present, tissue repair treatments present a major economic burden to the."

Similar presentations


Ads by Google